Skip to main content

Advertisement

Table 2 Patients’ baseline variables and presenting complaints

From: The clinical presentation, utilization, and outcome of individuals with sickle cell anaemia presenting to urban emergency department of a tertiary hospital in Tanzania

  Overall Died Survived Relative risk P-value
N = 752 N = 16 N = 736
Clinical characteristics n (%) n (%) n (%) RR (95%CI)  
Tachypnea b 336 (44.7) 10 (62.5) 326 (44.3) 2.1 (0.8–5.7) 0.16
Tachycardiab 186 (24.7) 5 (31.3) 181 (24.6) 1.4 (0.5–3.9) 0.5
Febrile (T > 37.5 °C)c 131 (17.4) 11 (68.8) 120 (16.3) 10.4 (3.7–29.5) < 0.0001
SpO2a < 95% 67 (8.9) 15 (93.8) 52 (7.1) 153 (20–1143) < 0.0001
Altered mental status 59 (7.8) 13 (81.3) 46 (6.3) 50 (15–174) < 0.0001
Bradycardiab 14 (1.9) 3 (18.8) 11 (1.5) 12.1 (3.9–38.0) < 0.0001
Pain 614 (81.6) 12 (75.0) 602 (81.8) 0.7 (0.2–2.1) 0.5
Fever 289 (38.4) 10 (62.5) 279 (37.9) 2.7 (1.0–7.3) 0.06
Abdominal Symptoms 159 (21.1) 2 (12.5) 157 (21.3) 0.5 (0.1–2.3) 0.4
Respiratory Symptoms 156 (20.7) 11 (68.8) 145 (19.7) 8.4 (3.0–23.8) 0.0001
Cardiovascular Symptoms 83 (11.0) 2 (12.5) 81 (11.0) 1.2 (0.3–5.0) 0.9
Jaundice 80 (10.6) 1 (6.3) 79 (10.7) 0.6 (0.1–4.2) 0.6
Body Swelling 54 (7.2) 2 (12.5) 52 (7.1) 1.9 (0.4–7.9) 0.4
Neurological Symptoms 45 (6.0) 6 (37.5) 39 (5.3) 9.4 (3.6–24.8) < 0.0001
Long Lasting Erection 20 (2.7) 1 (6.3) 19 (2.6) 2.4 (0.3–17.6) 0.4
Urinary Symptoms 6 (0.8) 1 (6.3) 5 (0.7) 8.3 (1.3–53.1) 0.03
  1. aSpO2 Saturation of oxygen in peripheral capillary bAge-adjusted variables c Measurements were all axillary